JP2016044170A5 - - Google Patents

Download PDF

Info

Publication number
JP2016044170A5
JP2016044170A5 JP2014172328A JP2014172328A JP2016044170A5 JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5 JP 2014172328 A JP2014172328 A JP 2014172328A JP 2014172328 A JP2014172328 A JP 2014172328A JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5
Authority
JP
Japan
Prior art keywords
stearic acid
excipient
olmesartan medoxomil
granulated product
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014172328A
Other languages
English (en)
Japanese (ja)
Other versions
JP6653116B2 (ja
JP2016044170A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014172328A priority Critical patent/JP6653116B2/ja
Priority claimed from JP2014172328A external-priority patent/JP6653116B2/ja
Publication of JP2016044170A publication Critical patent/JP2016044170A/ja
Publication of JP2016044170A5 publication Critical patent/JP2016044170A5/ja
Application granted granted Critical
Publication of JP6653116B2 publication Critical patent/JP6653116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014172328A 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤 Active JP6653116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019089234A Division JP6765473B2 (ja) 2019-05-09 2019-05-09 オルメサルタンのプロドラッグ製剤

Publications (3)

Publication Number Publication Date
JP2016044170A JP2016044170A (ja) 2016-04-04
JP2016044170A5 true JP2016044170A5 (https=) 2017-08-24
JP6653116B2 JP6653116B2 (ja) 2020-02-26

Family

ID=55635052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014172328A Active JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Country Status (1)

Country Link
JP (1) JP6653116B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6602779B2 (ja) 2014-02-13 2019-11-06 インサイト・コーポレイション Lsd1阻害剤としてのシクロプロピルアミン類
EP3105218B1 (en) 2014-02-13 2019-09-25 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
EP3277689B1 (en) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
MY189367A (en) 2015-08-12 2022-02-08 Incyte Corp Salts of an lsd1 inhibitor
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
MX2022008260A (es) * 2020-01-16 2022-08-04 Eisai R&D Man Co Ltd Sustancia farmacologica de lemborexant y composicion medicinal que la comprende.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123765A1 (ja) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited フィルムコーティング製剤
US20070105923A1 (en) * 2005-09-14 2007-05-10 Glenmark Pharmaceuticals Limited Substantially pure olmesartan medoxomil and processes for its preparation
ATE526963T1 (de) * 2006-05-04 2011-10-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit olmesartan- medoxomil
EP2141160A4 (en) * 2007-03-23 2011-06-29 Daiichi Sankyo Co Ltd GROUNDED CRYSTAL OF OLMESARTANMEDOXOMIL
WO2010018777A1 (ja) * 2008-08-11 2010-02-18 第一三共株式会社 におい抑制方法
TR201109686T2 (tr) * 2008-12-30 2012-03-21 Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ Olmesartan'ın Farmasötik Bileşimleri.
HUP0900384A2 (en) * 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate olmesartan medoxomil compositions
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2016044170A5 (https=)
JP2015078230A5 (https=)
JP2014221779A5 (https=)
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
RU2011141496A (ru) Таблетки и гранулированные порошки, содержащие 6-фтор-3-гидрокси-2-пиразинкарбоксамид
RU2020119391A (ru) Получение тетрациклического соединения, содержащегося в высокой дозе
EP4349406A3 (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole for use as a medicament
HK1232218A1 (zh) Cgrp-活性化合物的片剂制剂
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
AR121624A2 (es) Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos
EP4327880A3 (en) Solid state form of ribociclib succinate
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
PH12019500610A1 (en) Controlled release tablet based on polyvinyl alcohol and its manufacturing
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
IN2014DE03239A (https=)
JP2018513863A5 (https=)
EA201500513A1 (ru) Продукт сомикронизации, включающий ацетат улипристала
JP2017515879A5 (https=)
JP2014024874A5 (https=)
WO2012053785A3 (ko) 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛
JP2014218523A5 (https=)
JP2015129175A5 (https=)
JP2014062064A5 (https=)
JP2015129124A5 (https=)